This course has expired. Voir les cours disponibles.
Diabetes, Endocrinology
Remission vs. Regulation: Discussing Options for Patients with Type 2 Diabetes (SCFHS)
Recent evidence regarding diabetes remission has increased the number of options for patients with type 2 diabetes. This module will review the evidence for diabetes remission, as well as guideline recommendations for initiating therapy in patients with type 2 diabetes. It will also discuss the important role of the clinicians in engaging their patients in treatment decisions and individualizing treatment according to patient values, preferences, and priorities.
Durée
1 hr
Profession
Specialist
# des crédits
0
Accréditation
Unaccredited
Date d'expiration
2023-07-20
This module will review the evidence for diabetes remission, as well as guideline recommendations for initiating therapy in patients with type 2 diabetes. It will also discuss the important role of the clinicians in engaging their patients in treatment decisions and individualizing treatment according to patient values, preferences, and priorities.
This program has received an educational grant or in-kind support from Novo Nordisk.
La Faculté
Saud Al Sifri, FRCP
Objectifs d'apprentissage
Upon completion of this continuing education program participants will be better able to:
- Discuss the evidence for remission of diabetes
- Adjust or advance diabetes therapy in a timely manner according to local guidelines
- Start a conversation with patients to enable shared decision making for treatment adjustments
- Individualize treatment according to patient concerns and priorities
Accréditation
This program is accredited by the Saudi Commission for Health Specialties for 1.0 CPD hour(s).
Accreditation number: ACA-20220002142